Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $308,530 (100.0% shares, 0.0% debt)

Holdings (22)

— Medivation, Inc. 86.0%

Value ($000) $265,190 Shares 4,397,838 Est. Cost $45.85 Unrealized —

— Corbus Pharmaceuticals HLDGS 2.5%

Value ($000) $7,666 Shares 2,563,925 Est. Cost $2.53 Unrealized —

— Synthetic Biologics Inc. 2.2%

Value ($000) $6,721 Shares 3,734,149 Est. Cost $1.55 Unrealized —

— Alcobra Ltd 1.6%

Value ($000) $5,008 Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Ampio Pharmaceuticals Inc. 1.4%

Value ($000) $4,177 Shares 3,238,322 Est. Cost $6.03 Unrealized —

— Vascular Biogenics LTD 1.3%

Value ($000) $3,967 Shares 860,605 Est. Cost $4.61 Unrealized —

— Abeona Therapeutics Inc 1.0%

Value ($000) $3,209 Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Cempra Inc 1.0%

Value ($000) $2,981 Shares 180,800 Est. Cost $31.13 Unrealized —

— Advaxis Inc. 0.7%

Value ($000) $2,225 Shares 275,000 Est. Cost $9.03 Unrealized —

VNRX Volition RX LTD 0.5%

Value ($000) $1,454 Shares 461,538 Est. Cost $3.75 Unrealized -8.1%

— Keryx Biopharmaceuticals Inc. 0.4%

Value ($000) $1,324 Shares 200,000 Est. Cost $10.21 Unrealized —

— Newlink Genetics Corp 0.4%

Value ($000) $1,153 Shares 102,437 Est. Cost $27.98 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.3%

Value ($000) $773 Shares 135,800 Est. Cost $10.20 Unrealized -45.2%

— OHR Pharmaceutical Inc 0.2%

Value ($000) $562 Shares 205,000 Est. Cost $2.54 Unrealized —

— Advaxis Inc. 0.2%

Value ($000) $502 Shares 112,500 Est. Cost $6.02 Unrealized —

— Bio Blast Pharma Ltd 0.1%

Value ($000) $402 Shares 250,970 Est. Cost $7.27 Unrealized —

— Evoke Pharma Inc 0.1%

Value ($000) $381 Shares 55,660 Est. Cost $7.00 Unrealized —

— Caladrius Biosciences Inc 0.1%

Value ($000) $328 Shares 555,781 Est. Cost $1.87 Unrealized —

CSBR Champions Oncology INC 0.1%

Value ($000) $239 Shares 111,111 Est. Cost $4.66 Unrealized -29.1%

— Galmed Pharmaceuticals Ltd 0.1%

Value ($000) $224 Shares 49,947 Est. Cost $11.48 Unrealized —

— Aptose Biosciences Inc 0.0%

Value ($000) $29 Shares 11,933 Est. Cost $5.40 Unrealized —

— Zosano Pharma Corp 0.0%

Value ($000) $15 Shares 11,195 Est. Cost $10.10 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	4,397,838	$265,190	86.0%	$45.85	—	COM	58501N101
—	Corbus Pharmaceuticals HLDGS	2,563,925	$7,666	2.5%	$2.53	—	COM	21833P103
—	Synthetic Biologics Inc.	3,734,149	$6,721	2.2%	$1.55	—	COM	87164U102
—	Alcobra Ltd	1,115,315	$5,008	1.6%	$7.08	—	SHS	M2239P109
—	Ampio Pharmaceuticals Inc.	3,238,322	$4,177	1.4%	$6.03	—	COM	03209T109
—	Vascular Biogenics LTD	860,605	$3,967	1.3%	$4.61	—	COM	M96883109
—	Abeona Therapeutics Inc	1,359,767	$3,209	1.0%	$5.06	—	COM	00289Y107
—	Cempra Inc	180,800	$2,981	1.0%	$31.13	—	COM	15130J109
—	Advaxis Inc.	275,000	$2,225	0.7%	$9.03	—	COM NEW	7624208
VNRX	Volition RX LTD	461,538	$1,454	0.5%	$3.75	-8.1%	COM	928661107
—	Keryx Biopharmaceuticals Inc.	200,000	$1,324	0.4%	$10.21	—	COM	492515101
—	Newlink Genetics Corp	102,437	$1,153	0.4%	$27.98	—	COM	651511107
ALDX	Aldeyra Therapeutics Inc	135,800	$773	0.3%	$10.20	-45.2%	COM	01438T106
—	OHR Pharmaceutical Inc	205,000	$562	0.2%	$2.54	—	COM NEW	67778H200
—	Advaxis Inc.	112,500	$502	0.2%	$6.02	—	W EXP 07/15/201	7624117
—	Bio Blast Pharma Ltd	250,970	$402	0.1%	$7.27	—	SHS	M20156101
—	Evoke Pharma Inc	55,660	$381	0.1%	$7.00	—	COM	30049G104
—	Caladrius Biosciences Inc	555,781	$328	0.1%	$1.87	—	COM	128058104
CSBR	Champions Oncology INC	111,111	$239	0.1%	$4.66	-29.1%	COMM NEW	15870P307
—	Galmed Pharmaceuticals Ltd	49,947	$224	0.1%	$11.48	—	SHS	M47238106
—	Aptose Biosciences Inc	11,933	$29	0.0%	$5.40	—	COM NEW	03835T200
—	Zosano Pharma Corp	11,195	$15	0.0%	$10.10	—	COM	98979H103